JP Morgan Maintains Overweight on Privia Health Gr, Raises Price Target to $33
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Lisa Gill maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and raises the price target from $32 to $33.
JP Morgan analyst Lisa Gill maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and raises the price target from $32 to $33.